Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract

Completed

• Conditions: Functional Dyspepsia; Peptic Ulcer; Peptic Esophagitis; Irritable Bowel Syndrome; Inflammatory Bowel Diseases

• Registration Number: NCT00920400
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

Fecal calprotectin is a very sensitive non-invasive inflammation marker in the detection of inflammatory bowel disease and, to a lesser degree, has also proven to be useful in adenomatous polyps, neoplasias, and infectious gastroenteritis. Elevated calprotectin levels can also be found in patients with lesion only in the upper gastrointestinal tract. However, the diagnostic value of calprotectin has never been tested in this setting. The aim of the study is therefore to determine the diagnostic value of fecal calprotectin in patients with diseases of the upper gastrointestinal tract.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-03
• Study First Submitted: 2009-06-12
• Study First Submitted QC: 2009-06-12
• Study First Posted: 2009-06-15
• Primary Completion: 2009-09
• Study Completion: 2009-12
• Status Verified: 2010-01
• Last Update Submitted: 2010-01-11
• Last Update Posted: 2010-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 287

Inclusion Criteria

• All patients referred for upper gastrointestinal endoscopy for any reason
• Older than 18 years

Exclusion Criteria

• Patients who are not able to provide informed consent
• Patients who are not able to provide a stool sample

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Department of Gastroenterology & Hepatology; 🇨🇭 Basel, Basel-Stand, Switzerland